• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒是否会为毛霉菌病的传播创造环境?

Does COVID 19 generate a milieu for propagation of mucormycosis?

机构信息

Department of Oral Pathology and Microbiology, Saveetha Dental College and Hospitals, Chennai, Tamil Nadu, India; Department of Oral Pathology and Microbiology, Postgraduate Institute of Dental Sciences, Rohtak, Haryana, India.

Department of Oral Pathology and Microbiology, Postgraduate Institute of Dental Sciences, Rohtak, Haryana, India.

出版信息

Med Hypotheses. 2021 Jul;152:110613. doi: 10.1016/j.mehy.2021.110613. Epub 2021 May 26.

DOI:10.1016/j.mehy.2021.110613
PMID:34087613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8152198/
Abstract

Corona Virus Disease 2019 (COVID 2019), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a dreadful infectious disease which has emerged as one of the most significant medical emergency affecting everyone directly or indirectly. COVID 2019 is a multisystem disease and causes severe immunosuppression. Initially thought to affect mainly the respiratory system, it strikes all vital organ systems and cause defects in cardio-circulatory, respiratory system and gastrointestinal systems to name a few leading to copious biochemical alterations. Reports show there is thromoembolism, raised ferritin levels, lymphocytopenia, thrombocytopenia, lactic acidosis, acute diabetes like state and cytokine storm. Data regarding levels of neutrophils is equivocal. Further there is increased incidence regarding high incidents of mucormycosis in COVID 2019 positive subjects. In the present paper, we identified and correlated the virus mediated biochemical alterations as the potential ideal environment for propagation of mucorales; and thus concentrate on early diagnosis and treatment of mucormycosis in COVID 2019 cases.

摘要

2019 年冠状病毒病(COVID-19)由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起,是一种可怕的传染病,直接或间接地影响着每个人,是目前最重大的医疗紧急事件之一。COVID-19 是一种多系统疾病,可导致严重的免疫抑制。最初被认为主要影响呼吸系统,它会影响所有重要的器官系统,并导致心血管系统、呼吸系统和胃肠道系统等方面的缺陷,从而导致大量的生化改变。有报道称存在血栓栓塞、铁蛋白水平升高、淋巴细胞减少症、血小板减少症、乳酸酸中毒、类似急性糖尿病状态和细胞因子风暴。关于中性粒细胞水平的数据尚无定论。此外,COVID-19 阳性患者中曲霉菌病的发生率也有所增加。在本文中,我们确定并关联了病毒介导的生化改变,认为其为毛霉菌属繁殖的理想环境;因此,我们专注于 COVID-19 病例中毛霉菌病的早期诊断和治疗。

相似文献

1
Does COVID 19 generate a milieu for propagation of mucormycosis?新冠病毒是否会为毛霉菌病的传播创造环境?
Med Hypotheses. 2021 Jul;152:110613. doi: 10.1016/j.mehy.2021.110613. Epub 2021 May 26.
2
How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?黏液霉菌属如何从 SARS-CoV-2 感染期间失调的铁稳态中获益?
Mycopathologia. 2021 Dec;186(6):877-882. doi: 10.1007/s11046-021-00594-6. Epub 2021 Oct 8.
3
Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.2019冠状病毒病的免疫病理学及其在鼻眶脑毛霉菌病发展中的意义:一项重要综述
Orbit. 2022 Dec;41(6):670-679. doi: 10.1080/01676830.2022.2099428. Epub 2022 Jul 20.
4
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19.在2019冠状病毒病全球大流行背景下毛霉病、类固醇与糖尿病之间的相互影响
Crit Rev Microbiol. 2023 May;49(3):318-333. doi: 10.1080/1040841X.2022.2052795. Epub 2022 Mar 24.
5
COVID-19 and mucormycosis superinfection: the perfect storm.COVID-19 与毛霉菌感染:完美风暴。
Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24.
6
Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters.肺栓塞和弥漫性毛霉菌病伴胃出血——踏在危险的水域。
Monaldi Arch Chest Dis. 2022 Nov 25;93(3). doi: 10.4081/monaldi.2022.2418.
7
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者:一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
8
Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.纳米颗粒对与 COVID-19 相关的黑曲霉的抗真菌作用:对生物医学应用的展望。
Int J Mol Sci. 2022 Oct 19;23(20):12526. doi: 10.3390/ijms232012526.
9
COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms.COVID-19 相关毛霉菌病激增:多途径机制综述。
Parasite Immunol. 2024 Jan;46(1):e13016. doi: 10.1111/pim.13016. Epub 2023 Oct 17.
10
A systematic review on SARS-CoV-2-associated fungal coinfections.关于 SARS-CoV-2 相关真菌感染的系统评价。
J Med Virol. 2022 Jan;94(1):99-109. doi: 10.1002/jmv.27358. Epub 2021 Oct 5.

引用本文的文献

1
Invasive Sinusitis Presenting with Orbital Complications in COVID Patients: Is Mucor the Only Cause?新冠患者侵袭性鼻窦炎伴眶部并发症:毛霉菌是唯一病因吗?
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):55-63. doi: 10.1007/s12070-023-04077-6. Epub 2023 Jul 28.
2
COVID-19-Associated Rhinocerebral Mucormycosis, an Incidental Finding or a Matter of Concern - Mixed-Method Systematic Review.新型冠状病毒肺炎相关鼻脑毛霉菌病:偶然发现还是值得关注的问题——混合方法系统评价
Infect Drug Resist. 2024 Jan 31;17:387-402. doi: 10.2147/IDR.S445458. eCollection 2024.
3
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review.新冠病毒大流行后毛霉病的毒力特征和新型药物输送策略:全面综述。
Front Immunol. 2023 Sep 25;14:1264502. doi: 10.3389/fimmu.2023.1264502. eCollection 2023.
4
Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.眼眶毛霉菌病:了解席卷全球的致命真菌。
Cureus. 2023 Jun 26;15(6):e41010. doi: 10.7759/cureus.41010. eCollection 2023 Jun.
5
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics.用于 COVID-19 管理的血液过滤系统:细胞因子风暴治疗的新方法。
Front Immunol. 2023 Apr 21;14:1064459. doi: 10.3389/fimmu.2023.1064459. eCollection 2023.
6
Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study.巴基斯坦三级医院新冠肺炎相关毛霉菌病患者的发病率及生存率:一项回顾性观察研究。
Health Sci Rep. 2023 Feb 3;6(2):e1083. doi: 10.1002/hsr2.1083. eCollection 2023 Feb.
7
Chronic Invasive Aspergillosis with Fulminant Mucormycosis Sparing Palate in a Post-COVID-19 Patient - A Case Report.一名新冠康复患者出现慢性侵袭性曲霉病合并暴发性毛霉病,腭部未受累——病例报告
Ann Maxillofac Surg. 2022 Jan-Jun;12(1):102-105. doi: 10.4103/ams.ams_296_21. Epub 2022 Aug 16.
8
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.2019冠状病毒病相关毛霉病的当前治疗选择:现状与未来展望
J Clin Med. 2022 Jun 23;11(13):3620. doi: 10.3390/jcm11133620.
9
Oral Tissue Involvement and Probable Factors in Post-COVID-19 Mucormycosis Patients: A Cross-Sectional Study.新冠后毛霉菌病患者的口腔组织受累情况及可能因素:一项横断面研究
Healthcare (Basel). 2022 May 13;10(5):912. doi: 10.3390/healthcare10050912.
10
COVID-19 and Plethora of Fungal Infections.新型冠状病毒肺炎与多种真菌感染
Curr Fungal Infect Rep. 2022;16(2):47-54. doi: 10.1007/s12281-022-00432-2. Epub 2022 Apr 9.

本文引用的文献

1
Can COVID-19 cause severe neutropenia?新型冠状病毒肺炎会导致严重中性粒细胞减少症吗?
Clin Case Rep. 2020 Oct 26;8(12):3349-3351. doi: 10.1002/ccr3.3369. eCollection 2020 Dec.
2
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.SARS-CoV-2 感染后的一个具有挑战性的并发症:一例肺毛霉菌病。
Infection. 2021 Oct;49(5):1055-1060. doi: 10.1007/s15010-020-01561-x. Epub 2020 Dec 17.
3
Coronavirus disease 2019 and the pancreas.新型冠状病毒病 2019 与胰腺。
Pancreatology. 2020 Dec;20(8):1567-1575. doi: 10.1016/j.pan.2020.10.035. Epub 2020 Oct 12.
4
Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report.一名新冠肺炎患者发生罕见致命性胃肠道毛霉菌病(接合菌病):病例报告
Clin Endosc. 2020 Nov;53(6):746-749. doi: 10.5946/ce.2020.180. Epub 2020 Nov 19.
5
Gastrointestinal Manifestations and Associated Health Outcomes of COVID-19: A Brazilian Experience From the Largest South American Public Hospital.《COVID-19 的胃肠道表现及相关健康结局:来自南美最大公立医院的巴西经验》
Clinics (Sao Paulo). 2020 Oct 26;75:e2271. doi: 10.6061/clinics/2020/e2271. eCollection 2020.
6
SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.严重急性呼吸综合征冠状病毒 2 细胞进入受体血管紧张素转换酶 2 介导的内皮功能障碍导致 COVID-19 患者血管血栓形成。
Med Hypotheses. 2020 Dec;145:110320. doi: 10.1016/j.mehy.2020.110320. Epub 2020 Sep 30.
7
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment.新型冠状病毒肺炎(COVID-19):对其发病机制、临床表现和治疗的最新认识。
Postgrad Med J. 2021 May;97(1147):312-320. doi: 10.1136/postgradmedj-2020-138577. Epub 2020 Sep 25.
8
Mucormycosis with orbital compartment syndrome in a patient with COVID-19.COVID-19 患者合并眼窝间隔综合征的毛霉菌病。
Am J Emerg Med. 2021 Apr;42:264.e5-264.e8. doi: 10.1016/j.ajem.2020.09.032. Epub 2020 Sep 16.
9
COVID-19 presenting as neutropenic fever.表现为中性粒细胞减少性发热的新型冠状病毒肺炎。
Ann Hematol. 2020 Aug;99(8):1939-1940. doi: 10.1007/s00277-020-04128-w. Epub 2020 Jun 13.
10
COVID-19 may affect the endocrine pancreas by activating Na/H exchanger 2 and increasing lactate levels.新型冠状病毒肺炎可能通过激活钠/氢交换体2和增加乳酸水平来影响胰腺内分泌。
J Endocrinol Invest. 2020 Aug;43(8):1167-1168. doi: 10.1007/s40618-020-01307-4. Epub 2020 May 28.